David Fenster

Title: David Fenster: Innovator in Clinical Trial Systems

Introduction

David Fenster is a notable inventor based in Jersey City, NJ (US). He has made significant contributions to the field of clinical trials through his innovative patent. His work focuses on enhancing the efficiency and effectiveness of clinical trial management.

Latest Patents

David Fenster holds a patent for "Distributed randomization and supply management in clinical trials." This patent describes a distributed clinical trial system that offers configurability, reusability, and integration of randomization and inventory configurations for various clinical trials utilizing different electronic data capture (EDC) systems. The system includes a method for randomizing subjects in a multi-arm clinical trial. It involves receiving a subject identifier and a trial identifier from an EDC system, retrieving a previously configured randomization design from a database, and assigning the subject identifier to an arm identifier based on the randomization design. This innovative approach streamlines the process of managing clinical trials.

Career Highlights

David Fenster is currently employed at Medidata Solutions, Inc., where he continues to develop and refine clinical trial technologies. His expertise in this area has positioned him as a valuable asset to his organization and the broader medical research community.

Collaborations

David has collaborated with notable colleagues, including Benjamin Young and Glen De Vries. These partnerships have fostered an environment of innovation and have contributed to the advancement of clinical trial methodologies.

Conclusion

David Fenster's contributions to clinical trial systems exemplify the impact of innovation in healthcare. His patent and ongoing work at Medidata Solutions, Inc. highlight the importance of improving clinical trial processes for better patient outcomes.